
|Slideshows|April 27, 2016
In This Issue: Volume 33, No. 3
Author(s)Natalie Timoshin
Check out what's new in schizophrenia research, personality disorders, patient education, integrative psychiatry, addiction, and more.
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
2
New Data on Lumateperone for Prevention of Relapse in Schizophrenia
3
Phase 3 Data Support CT-155 as a Novel Digital Therapeutic for Negative Symptoms in Schizophrenia at ECNP
4
Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder
5